Bayer names Christoph Koenen chief medical officer

By Public Technologies
  • Bayer appointed Dr. Christoph Koenen as chief medical officer, effective Oct. 1, 2026.
  • Koenen will lead medical and scientific strategy in the pharma division.
  • He will retain his role as head of clinical development and operations at the pharmaceuticals unit.
  • Koenen has more than 25 years of global pharma industry experience, including senior roles at Bayer, Bristol Myers Squibb, Novo Nordisk, Boehringer Ingelheim, GSK.
  • He joined Bayer in 2022 from Otsuka Pharmaceutical, where he served as chief medical officer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on October 01, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk